Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiCanadian National to Invest $50M in Louisiana for Rail Innovation
DiCNA Stock Trading at a Discount to Industry at 1.22X: Time to Hold?
DiAPH Scales Through Acquisitions: Is the Growth Thesis Strengthening?
DiCan Lemonade's Reinsurance Renewal Boost Financial Flexibility?
DiIs Zscaler Stock a Buy, Sell or Hold at a P/S Multiple of 15.56X?
DiIs It Time for NIKE and Target to Shine Again?
DiCan Sprouts Farmers Sustain Its 11.7% Comp Sales Momentum?
DiThe J. M. Smucker Slides 12% in a Month: How to Play SJM Stock
DiRigetti vs. D-Wave: Which Quantum Computing Stock Has Better Prospects?
DiCan IonQ Maintain Its Quantum Edge With China Advancing Fast?
Di2 AI Infrastructure Stocks Nobody is Talking About (AEIS, DBRG)
DiCan C3.ai's New HII Deal Boost Its Defense AI Momentum?
DiBlackRock Dissolves Private Credit Partnership With Mubadala in Asia
DiTarget Circle Week 2025: Will It Boost Back-to-School Sales Early?
DiHow is Starbucks Navigating Tariffs and Price Volatility in FY25?
DiGap Bets on Athleta Again: Is the Brand Still in Shape to Compete?
DiHOOD Launches Tokenized Stocks in EU: Betting on Digital Asset Boom?
DiBiogen Begins Phase III Felzartamab Study for Third Kidney Disease
DiOlin Set to Expand Bleach Distribution With K2 Partnership
DiIntel Collaborates With Exostellar to Scale AI Initiatives Faster
DiFMC's Tremisia Fungicide Debuts in EMEA Region After Approvals
DiPLMR Outperforms Industry, Trades at Premium: How to Play the Stock
DiPetrobras Enhances FPSO Safety With Exail's Quadrans AHRS Tech
DiRivian Lays Off 140 Workers to Boost R2 SUV Production Efficiency
DiABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B